Login / Signup

Human activities have reduced plant diversity in eastern China over the last two millennia.

Xianyong CaoFang TianUlrike HerzschuhJian NiQinghai XuWen-Jia LiYanrong ZhangMingyu LuoFahu Chen
Published in: Global change biology (2022)
Understanding the history and regional singularities of human impact on vegetation is key to developing strategies for sustainable ecosystem management. In this study, fossil and modern pollen datasets from China are employed to investigate temporal changes in pollen composition, analogue quality, and pollen diversity during the Holocene. Anthropogenic disturbance and vegetation's responses are also assessed. Results reveal that pollen assemblages from non-forest communities fail to provide evidence of human impact for the western part of China (annual precipitation less than 400 mm and/or elevation more than 3000 m.a.s.l.), as inferred from the stable quality of modern analogues, principal components, and diversity of species and communities throughout the Holocene. For the eastern part of China, the proportion of fossil pollen spectra with good modern analogues increases from ca. 50% to ca. 80% during the last 2 millennia, indicating an enhanced intensity of anthropogenic disturbance on vegetation. This disturbance has caused the pollen spectra to become taxonomically less diverse over space (reduced abundances of arboreal taxa and increased abundances of herbaceous taxa), highlighting a reduced south-north differentiation and divergence from past vegetation between regions in the eastern part of China. We recommend that care is taken in eastern China when basing the development of ecosystem management strategies on vegetation changes in the region during the last 2000 years, since humans have significantly disturbed the vegetation during this period.
Keyphrases
  • climate change
  • endothelial cells
  • south africa
  • healthcare
  • induced pluripotent stem cells
  • human health
  • quality improvement
  • gene expression
  • dna methylation
  • single cell
  • molecular docking
  • risk assessment
  • chronic pain